Loren Stefan
Transaction: 07/08/2026
BUY
Change
+15,000
Price
$2.69
Filing
07/10/2026
Type
BUY
Cellectar Biosciences, Inc.
CLRB • Biotechnology
$2.37
▲ +0.02 (+0.85%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$28.99M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 2.96Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:34 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.37
Change0.85%
Shares Out12.23M
Market Cap$28.99M
Enterprise Value$-3.47M
52W Range2.20 - 6.52
Beta0.55
P/E-1.30
P/B0.97
P/FCF-3.36
EV/EBITDA0.15
EV/FCF0.40
Price$2.37
Change0.85%
Shares Out12.23M
Market Cap$28.99M
Enterprise Value$-3.47M
52W Range2.20 - 6.52
Beta0.55
P/E-1.30
P/B0.97
P/FCF-3.36
EV/EBITDA0.15
EV/FCF0.40
Earnings Yield-77.01%
FCF Yield-29.76%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio2.96
Quick Ratio2.96
Revenue 5Y-100.00%
Target$11.00
Target Upside364.14%
Target Median$11.00
Target Range11.00 - 11.00
Volume29.29K
Avg Volume1.07M
EPS Surprise0.56
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 2.96Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
94/100
Bullish
Bullish
7
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$11.00
Mean
$11.00
Median
$11.00
High
$11.00
Insider Transactions
Recent executive and insider activity
Loren Stefan
Transaction: 07/08/2026
BUY
Change
+15,000
Price
$2.68
Filing
07/08/2026
Type
BUY
NEIS JOHN
Transaction: 07/07/2026
BUY
Change
+25,000
Price
$2.70
Filing
07/08/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Loren Stefan | BUY | +15,000 | $2.69 | 07/08/2026 | 07/10/2026 |
| Loren Stefan | BUY | +15,000 | $2.68 | 07/08/2026 | 07/08/2026 |
| NEIS JOHN | BUY | +25,000 | $2.70 | 07/07/2026 | 07/08/2026 |
| Swirsky Douglas J | BUY | +37,500 | $2.70 | 07/07/2026 | 07/08/2026 |
| Longcor Jarrod | BUY | +118,000 | $3.14 | 07/07/2026 | 07/08/2026 |
| Gu Andrew | BUY | +25,000 | $2.70 | 07/07/2026 | 07/08/2026 |
| CARUSO JAMES V | BUY | +250,000 | $3.14 | 07/07/2026 | 07/08/2026 |
| Chanan-Khan Asher | BUY | +25,000 | $2.70 | 07/07/2026 | 07/08/2026 |
| DRISCOLL FREDERICK W | BUY | +25,000 | $2.70 | 07/07/2026 | 07/08/2026 |
| Kolean Chad J | BUY | +92,000 | $3.14 | 07/07/2026 | 07/08/2026 |
| Gu Andrew | OTHER | 0 | Not reported | 05/18/2026 | 06/09/2026 |
| CARUSO JAMES V | BUY | +8,680 | $2.88 | 05/07/2026 | 05/11/2026 |
| CARUSO JAMES V | BUY | +26,040 | $2.88 | 05/07/2026 | 05/11/2026 |
| Longcor Jarrod | BUY | +8,680 | $2.88 | 05/07/2026 | 05/11/2026 |
| Longcor Jarrod | BUY | +26,040 | $2.88 | 05/07/2026 | 05/11/2026 |
| NEIS JOHN | SELL | -198 | $3.70 | 12/12/2025 | 12/16/2025 |
| Kolean Chad J | BUY | +5,000 | $5.25 | 07/02/2025 | 07/03/2025 |
| Kolean Chad J | BUY | +5,000 | $4.99 | 07/02/2025 | 07/03/2025 |
| Longcor Jarrod | BUY | +10,000 | $5.25 | 07/02/2025 | 07/03/2025 |
| Longcor Jarrod | BUY | +10,000 | $4.99 | 07/02/2025 | 07/03/2025 |